A PBPK Model for Cobicistat, a Potential Strong CYP3A4 Inhibitor for Clinical DDI Studies with CYP3A4 Victim Drugs

Author(s): L Almond, AB Ke, K Rowland‐Yeo
Year:

Learn More LinkedIn Twitter Facebook Email